Hi Zecs, it’s my understanding that the trial has finished and the data is being reviewed. This will take up to two months by the time the data has been cleaned and analysed.
I recall from an announcement that the blood levels of the first 18 cohort didn’t t rise and in some cases reduced. I think that with a stronger “hit” of Veyonda that we’ll see compelling results and considerable reductions in the blood bio markers. IMO
HODL
Ann: Noxopharm Corporate Presentation, page-3
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
